References
- Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Br Med J 1988; 297: 943–8
- Kronborg O, Fenger C, Sondergaard O, Pedersen KM, Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1987; 22: 677–86
- Kronborg O, Fenger C, Olsen J, Bech K, Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989; 24: 599–606
- Kronborg O, Fenger C, Worm J, et al. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1991; 27: 47–52
- Klaaborg K, Madsen MS, Søndergaard O, Kronborg O. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1986; 21: 1180–4
- Hardcastle JD, Chamberlain J, Sheffield J, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107349 subjects. Lancet 1989; 1: 1160–4
- Kewenter J, Björk S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988; 62: 645–51
- Kronborg O. Population screening for colorectal cancer, the goals and means. Ann Med 1991; 23: 373–9
- Thomas WM, Pye G, Hardcastle JD, Mangham CM. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of test. Br J Surg 1990; 77: 277–9
- Hakkinen I, Paasivuo R, Partanen P. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects. Gut 1988; 29: 1194–7
- St John DJB. Faecal occult blood tests-a critical review. Screening for colorectal cancer, JD Hardcastle. Normed Verlag, En-glewood (NJ) 1990; 54–68